Qiagen N.V.
NYSE:QGEN
43.08 (USD) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Qiagen N.V. |
Symbool | QGEN |
Munteenheid | USD |
Prijs | 43.08 |
Beurswaarde | 9,557,168,760 |
Dividendpercentage | 2.91% |
52-weken bereik | 37.51 - 47.44 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Thierry Bernard |
Website | https://www.qiagen.com |
An error occurred while fetching data.
Over Qiagen N.V.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)